Most just lately, it has been recognized that conolidine and the above derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in equivalent places as classical opioid receptors, it binds to some wide array of endogenous opioids. Unlike most opioid receptors, this receptor acts as a scavenger and isn't going to activate a second